Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2810767

CN(C)C(C)(C)c1ccccc1.Cl

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 2/20 0.39
ESR2 known ✓ Q92731 2/20 0.39
CHRM2 known ✓ P08172 1/20 0.38
CHRM4 known ✓ P08173 1/20 0.38
CHRM5 known ✓ P08912 1/20 0.38
CHRM1 known ✓ P11229 1/20 0.38
CHRM3 known ✓ P20309 1/20 0.38
KCNN4 O15554 3/20 0.56
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
ALDH1A1 P00352 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ALOX15 P16050 1/20 0.41
LMNA P02545 2/20 0.40
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 2/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1149712 0.97 KCNN4 (0.59) KCNN4MAPK1SMN1; SMN2ALDH1A1TAAR1
SCHEMBL11623543 0.84 KCNN4 (0.46) KCNN4MAPK1ALDH1A1TAAR1ALOX15
SCHEMBL9245412 0.83 KIF11 (0.48) KCNN4MAPK1ALDH1A1TAAR1CYP3A4
SCHEMBL29286845 0.77 KCNN4 (0.48) KCNN4MAPK1SMN1; SMN2ALDH1A1TAAR1
SCHEMBL13786373 0.75 KCNN4 (0.46) KCNN4MAPK1SMN1; SMN2ALDH1A1TAAR1
SCHEMBL14236873 0.74 KCNN4 (0.44) KCNN4MAPK1ALDH1A1TAAR1ALOX15
SCHEMBL35577 0.74 ALDH1A1 (0.46) KCNN4MAPK1SMN1; SMN2ALDH1A1TAAR1
SCHEMBL14306333 0.74 KCNN4 (0.44) KCNN4MAPK1ALDH1A1TAAR1ALOX15
SCHEMBL2154174 0.74 KCNN4 (0.56) KCNN4MAPK1SMN1; SMN2ALDH1A1TAAR1
SCHEMBL8354395 0.74 TSHR (0.55) KCNN4ALDH1A1MAPTKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2729169-A1 HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE Nanobio Corporation (US) 2014-05-14 EP claimed
WO-2013006797-A1 HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE NANOBIO CORPORATION (US) 2013-01-10 WO claimed
WO-2026101847-A1 METHODS OF INFLUENZA VACCINATION AND COMPOSITIONS FOR THE SAME BLUEWILLOW BIOLOGICS, INC. (US) 2026-05-15 WO disclosed
US-20240074434-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2024-03-07 US disclosed
US-20240065262-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2024-02-29 US disclosed
WO-2023154183-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY (US) 2023-08-17 WO disclosed
US-20230172194-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY HANSON (US) 2023-06-08 US disclosed
US-20220272987-A1 COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE ROBBINS JEFFREY H (US) 2022-09-01 US disclosed
EP-2207416-B1 ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM IMERYS FILTRATION MINERALS INC (US) 2018-11-07 EP disclosed
EP-2747779-A1 HERPES SIMPLEX VIRUS NANOEMULSION VACCINE Nanobio Corporation (US) 2014-07-02 EP disclosed
WO-2013028738-A1 HERPES SIMPLEX VIRUS NANOEMULSION VACCINE NANOBIO CORPORATION (US) 2013-02-28 WO disclosed
US-7259133-B2 Fabric care compositions for lipophilic fluid systems containing an antimicrobial agent THE PROCTER & GAMBLE COMPANY (US) 2007-08-21 US disclosed
US-7220715-B2 Fabric care compositions for lipophilic fluid systems incorporating an antimicrobial agent THE PROCTER & GAMBLE CO. (US) 2007-05-22 US disclosed
US-20060123562-A1 Fabric care compositions for lipophilic fluid systems incorporating an antimicrobial agent GHOSH CHANCHAL K 2006-06-15 US disclosed
EP-1639184-A1 FABRIC CARE COMPOSITIONS FOR LIPOPHILIC FLUID SYSTEMS INCORPORATING AN ANTIMICROBIAL AGENT THE PROCTER & GAMBLE COMPANY (US) 2006-03-29 EP disclosed
EP-1639185-A1 FABRIC CARE COMPOSITIONS FOR LIPOPHILIC FLUID SYSTEMS CONTAINING AN ANTIMICROBIAL AGENT The Procter & Gamble Company (US) 2006-03-29 EP disclosed
WO-2005003436-A1 FABRIC CARE COMPOSITIONS FOR LIPOPHILIC FLUID SYSTEMS INCORPORATING AN ANTIMICROBIAL AGENT THE PROCTER & GAMBLE COMPANY (US) 2005-01-13 WO disclosed
WO-2005003437-A1 FABRIC CARE COMPOSITIONS FOR LIPOPHILIC FLUID SYSTEMS CONTAINING AN ANTIMICROBIAL AGENT THE PROCTER & GAMBLE COMPANY (US) 2005-01-13 WO disclosed
US-20040261195-A1 Fabric care compositions for lipophilic fluid systems containing an antimicrobial agent THE PROCTER & GAMBLE COMPANY 2004-12-30 US disclosed
US-20040261196-A1 Fabric care compositions for lipophilic fluid systems incorporating an antimicrobial agent THE PROCTER & GAMBLE COMPANY 2004-12-30 US disclosed